A portable smartphone-based fluorescence sensing platform specifically designed to address the limitations of existing exosome assays in portability, quantitative robustness, and operational simplicity is reported.
Abstract
Exosomes play a crucial role in intercellular communication and have emerged as promising biomarkers for disease diagnosis and prognosis, however, their nanoscale size and low abundance in biological fluids pose substantial challenges for rapid and quantitative detection. Conventional detection techniques rely on bulky instrumentation and complex workflows that hinder point-of-care implementation. Here, we report a portable smartphone-based fluorescence sensing platform specifically designed to address the limitations of existing exosome assays in portability, quantitative robustness, and operational simplicity. Exosome capture was achieved through a CD63-specific aptamer, followed by molecular recognition using a FAM-labeled, tumor-specific aptamer. A miniaturized optical readout device integrating an excitation unit, optical filters, and an imaging module enables fluorescence acquisition and quantitative analysis without large laboratory equipment. The system completes exosome detection within 45 min and achieves a limit of detection of 4.58 × 106 particles/ml. Clinical sample analysis preliminarily demonstrates the feasibility of serum exosome detection using this portable platform, suggesting its potential utility for rapid, on-site biomedical screening.
Exosomes are nano-sized extracellular vesicles secreted by cells and they have emerged as promising biomarkers for non-invasive clinical diagnostics. However, their small size (30–200 nm) and low abundance in biofluids pose significant challenges for isolation and detection. This review highlights recent advances in el...
María Isabel Pividori Gurgo· Brazilian Journal of Analyti...· 0 citations
This review discusses current breakthroughs in aptamer and peptide functionalized microfluidic biosensors for exosome-based cancer diagnostics, focusing on their translation into POC applications, and highlights present challenges, as well as potential future prospects.
P. Priyanka, S. Hemalatha· Microfluidics and Nanofluidi...· 0 citations
The sensitive, point-of-care detection of acute myeloid leukemia (AML)-derived exosomes is essential for non-invasive diagnosis and therapy monitoring, but remains technically challenging. Here we report a colorimetric biosensor based on a dual -aptamer-initiated catalytic cascade, where simultaneous recognition of exo...
Ying Shen, Yunlong Xiao, Lu Liu et al.· Analytica Chimica Acta· 0 citations
Microribonucleic acids (microRNAs, miRNAs) are important emerging biomarkers, yet their detection in clinical samples remains challenging due to their low concentrations and matrix effects, which typically require complex workflows including miRNA extraction, reverse transcription, and amplification. Here, we introduce...
Jan Bukáček, Tomáš Špringer, Z. Krejčík et al.· Biosensors & bioelectronics· 0 citations
A matrix-oriented framework for assessing the translational potential of nanomaterial-enabled anti-doping sensors is defined, linking material design, sensing format, matrix-specific validation, and practical deployment requirements.
Shaoquan Chu, Qiyuan Jing· Analytical and Bioanalytical...· 0 citations
An electrochemical biosensor that enables sensitive and specific detection of exosomes without the requirement of pretreatment steps and signal amplification is reported, demonstrating its potential for early diagnosis of the cancer.